Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

AbortionAbortion Drugs

The Shrouded Dangers of the Abortion Pill

Over three years have passed since Roe v. Wade’s overturning, and yet, abortion pill usage has surged in the U.S.

Despite the mounting data revealing the life-threatening risks abortion drugs pose to women, more than 60% percent of abortions in the U.S. are executed via medication, a 53% increase since 2020. Meanwhile, abortion bans are enforced across 13 states, and early gestational limits have been adopted in six. Analysts identify a shift toward telehealth appointments and drug shipments via mail as the catalyst for greater access to abortion pills following the FDA’s removal in 2021 of the requirement for in-person doctor appointments. Beyond telehealth, drugs can be ordered through online websites without the provider or patient seeing each other.

Continue Reading at Decision >>

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

Abortion Reporting: Kentucky (2025)

Abortion Reporting: Alabama (2025)

Abortion Reporting: Virginia (2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image